Cite
HARVARD Citation
Katayama, A. et al. (2022). The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer. Histopathology. 81 (4), pp. 511-519. [Online].